公司概覽
業務類別 Biotechnology
業務概覽 Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
公司地址 101 Redwood Shores Parkway, Redwood City, CA, USA, 94065
電話號碼 +1 650 327-3270
傳真號碼 +1 650 327-3218
公司網頁 https://www.corcept.com
員工數量 730
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Joseph K. Belanoff, M.D. Director, President and Chief Executive Officer 美元 1.18M 17/04/2026
Mr. G. Charles Robb Chief Business Officer and Secretary 美元 711.41K 17/04/2026
Mr. Atabak Mokari Chief Financial Officer and Treasurer 美元 566.35K 17/04/2026
Mr. Joseph Douglas Lyon Chief Accounting Officer and Chief Technology Officer -- 17/04/2026
Dr. Hazel Hunt, PhD Chief Scientific Officer -- 17/04/2026
Dr. William Guyer, Pharm.D. Chief Development Officer 美元 706.39K 17/04/2026
Mr. Justin Gunn President, Corcept Endocrinology -- 23/09/2026
 
董事會成員
董事會 職務 更新日期
Mr. David L. Mahoney Independent Director 17/04/2026
Mr. Daniel N. Swisher,Jr Independent Director 17/04/2026
Mr. George Leonard Baker, Jr Independent Director 17/04/2026
Dr. Gregg H. Alton, J.D. Independent Director 17/04/2026
Dr. Joseph K. Belanoff, M.D. Director, President and Chief Executive Officer 17/04/2026
Mr. James N. Wilson Chairman of the Board 17/04/2026
Ms. Kimberly Park Independent Director 17/04/2026
Mr. Joshua M. Murray Independent Director 17/04/2026
 
所屬ETF (更新日期: 07/11/2026 04:23)
代號 名稱 佔比% ▼ 持有日期
JHMLJHancock Multifactor Large Cap ETF0.001%30/10/2026
BRSMMFS Blended Research Small-Mid Cap ETF0.0005%30/10/2026
UMDDProShares UltraPro MidCap4000.0004%30/10/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0004%31/05/2023
MFIGMotley Fool Innovative Growth Factor ETF0.0004%30/10/2026
AVUSAvantis US Equity ETF0.0003%30/10/2026
PLTLPrincipal US Small-Cap Adptv Mlt-Fac ETF0.0003%30/09/2023
SQLTIshares MSCI USA Small-Cap Qul Fac ETF0.0003%30/10/2026
MMTMState Street® SPDR® S&P® 1500MomtTiltETF0.0003%30/10/2026
STXGStrive 1000 Growth ETF0.0002%30/10/2026
MFMOMotley Fool Momentum Factor ETF0.0002%30/10/2026
MCOWPacer S&P MidCp 400 Qul FCF Arstcrts ETF0.0002%30/10/2026
AVTMAvantis Total Equity Markets ETF0.0002%30/10/2026
QMIDWisdomTree U.S. Mid Cap Quality Gr0.0002%30/10/2026
HQGOHartford US Quality Growth ETF0.0001%31/10/2026
FFFFounders 100 ETF0.0001%30/10/2026
REMCColumbia Research Enhanced Mid Cap ETF0.0001%31/10/2026
MNZLManzil Russell Halal USA Broad MarketETF0.0001%30/10/2026
FEMGFidelity Enhanced Mid Cap Growth ETF0.0001%30/10/2026
AVIEAvantis Inflation Focused Equity ETF0.0001%30/10/2026
  1    2    3    4    5   6    7    8    9    10  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.